SCHEMBL5085753

SCHEMBL5085753

CCCOC(=O)c1ccc([C]=O)c(C(=O)c2ccc(C(=O)OC)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.48
TDP1 Q9NUW8 2/20 0.48
ESR1 P03372 2/20 0.48
TSHR P16473 2/20 0.48
CHRM1 P11229 1/20 0.48
SLC6A2 P23975 1/20 0.48
KDR P35968 1/20 0.48
KDM4E B2RXH2 2/20 0.47
POLB P06746 1/20 0.47
HPGD P15428 5/20 0.46
LMNA P02545 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RAB9A P51151 3/20 0.41
STS P08842 1/20 0.41
MAPT P10636 4/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 2/20 0.40
MEN1 O00255 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL680463 0.79 ALDH1A1 (0.72) ALDH1A1TDP1ESR1TSHRCHRM1
SCHEMBL7014391 0.78 KDM4E (0.54) ALDH1A1TDP1TSHRKDM4EHPGD
SCHEMBL15315290 0.75 KDM4E (0.59) ALDH1A1TDP1ESR1TSHRCHRM1
SCHEMBL9868709 0.75 TDP1 (0.66) ALDH1A1TDP1ESR1TSHRCHRM1
SCHEMBL5166192 0.73 LMNA (0.66) ALDH1A1TDP1ESR1TSHRCHRM1
Propylparaben SCHEMBL6130230 0.73 ESR1 (0.86) ALDH1A1TDP1ESR1TSHRCHRM1
Propylparaben SCHEMBL1078675 0.73 ESR1 (0.86) ALDH1A1TDP1ESR1TSHRCHRM1
SCHEMBL9816116 0.73 KDM4E (0.45) ALDH1A1TDP1TSHRKDM4EHPGD
SCHEMBL18459949 0.73 LMNA (0.58) ALDH1A1TDP1ESR1TSHRCHRM1
SCHEMBL49950 0.72 ALDH1A1 (0.84) ALDH1A1TDP1ESR1TSHRCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008137780-A2 USE OF [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES NEREUS PHARMACEUTICALS, INC. (US) 2008-11-13 WO disclosed